NODAL and melanoma: With respect to melanoma, Nodal expression in melanoma tissue would not only justify selection of patients for anti-Nodal therapy, but this novel 3D1 mAb-based ELISA could provide the ability to assess pre-therapeutic Nodal levels, important for dosing and scheduling of the Nodal targeting agent for reasons mentioned previously.